| Drug Interactions with TOLSURA that Increase Concomitant Drug Concentrations and May Increase Risk of Adverse Reactions Associated with the Concomitant Drug |
| Alpha Blockers |
Alfuzosin Silodosin Tamsulosin | Not recommended during and 2 weeks after TOLSURA treatment. |
| Analgesics |
| Methadone | Contraindicated during and 2 weeks after TOLSURA treatment. |
| Fentanyl | Not recommended during and 2 weeks after TOLSURA treatment. |
Alfentanil Buprenorphine (IV and sublingual) Oxycodone
Sufentanil | Monitor for adverse reactions. Concomitant drug dose reduction may be necessary. |
| Antiarrhythmics |
Disopyramide Dofetilide Dronedarone Quinidine
| Contraindicated during and 2 weeks after TOLSURA treatment. |
| Digoxin
| Monitor for adverse reactions. Concomitant drug dose reduction may be necessary. |
| Antibacterials |
| Bedaquiline
| Concomitant TOLSURA not recommended for more than 2 weeks at any time during bedaquiline treatment. |
| Rifabutin | Not recommended 2 weeks before, during, and 2 weeks after TOLSURA treatment. See also Table 5. |
| Clarithromycin | Monitor for adverse reactions. Concomitant drug dose reduction may be necessary. See also Table 5. |
| Trimetrexate | Monitor for adverse reactions. Concomitant drug dose reduction may be necessary. |
| Anticoagulants and Antiplatelets |
| Ticagrelor | Contraindicated during and 2 weeks after TOLSURA treatment. |
Apixaban Rivaroxaban Vorapaxar | Not recommended during and 2 weeks after TOLSURA treatment. |
Cilostazol Dabigatran Warfarin | Monitor for adverse reactions. Concomitant drug dose reduction may be necessary. |
| Anticonvulsants |
| Carbamazepine | Not recommended 2 weeks before, during, and 2 weeks after TOLSURA treatment. See also Table 5. |
| Antidiabetic Drugs |
Repaglinide
Saxagliptin | Monitor for adverse reactions. Concomitant drug dose reduction may be necessary. |
| Antihelminthics, Antifungals and Antiprotozoals |
| Isavuconazonium | Contraindicated during and 2 weeks after TOLSURA treatment. |
| Praziquantel | Monitor for adverse reactions. Concomitant drug dose reduction may be necessary. |
Artemether-lumefantrine Quinine
| Monitor for adverse reactions. |
| Antimigraine Drugs |
| Ergot alkaloids (e.g., dihydroergotamine, ergotamine) | Contraindicated during and 2 weeks after TOLSURA treatment. |
| Eletriptan | Monitor for adverse reactions. Concomitant drug dose reduction may be necessary |
| Antineoplastics |
| Irinotecan | Contraindicated during and 2 weeks after TOLSURA treatment. |
Axitinib Bosutinib Cabazitaxel Cabozantinib Ceritinib Cobimetinib
Crizotinib Dabrafenib Dasatinib | Docetaxel Ibrutinib Lapatinib Nilotinib Olaparib
Pazopanib Sunitinib Trabectedin Trastuzumab-emtansine Vinca alkaloids | Not recommended during and 2 weeks after TOLSURA treatment. |
Bortezomib Brentuximab-vedotin Busulfan
Erlotinib Gefitinib
Idelalisib Imatinib Ixabepilone | Nintedanib Panobinostat Ponatinib Ruxolitinib Sonidegib Vandetanib
| Monitor for adverse reactions. Concomitant drug dose reduction may be necessary. For Idelalisib, see also Table 5. |
| Antipsychotics, Anxiolytics and Hypnotics |
Alprazolam
Aripiprazole
Buspirone
Diazepam
Haloperidol
| Midazolam (IV)
Quetiapine Ramelteon Risperidone
Suvorexant | Monitor for adverse reactions. Concomitant drug dose reduction may be necessary. |
| Zopiclone
| Monitor for adverse reactions. Concomitant drug dose reduction may be necessary. |
Lurasidone Midazolam (oral)
Pimozide Triazolam
| Contraindicated during and 2 weeks after TOLSURA treatment. |
| Antivirals |
| Simeprevir | Not recommended during and 2 weeks after TOLSURA treatment. |
Daclatasvir Indinavir
Maraviroc | Monitor for adverse reactions. Concomitant drug dose reduction may be necessary. For indinavir, see also Table 5. |
Cobicistat Elvitegravir (ritonavir-boosted) Ritonavir Saquinavir (unboosted)
| Monitor for adverse reactions. See also Table 5. |
| Tenofovir disoproxil fumarate | Monitor for adverse reactions. |
| Beta Blockers |
| Nadolol
| Monitor for adverse reactions. Concomitant drug dose reduction may be necessary. |
| Calcium Channel Blockers |
Felodipine
Nisoldipine | Contraindicated during and 2 weeks after TOLSURA treatment. |
Diltiazem Other dihydropyridines Verapamil | Monitor for adverse reactions. Concomitant drug dose reduction may be necessary. For diltiazem, see also Table 5. |
Cardiovascular Drugs, Miscellaneous |
Ivabradine Ranolazine | Contraindicated during and 2 weeks after TOLSURA treatment. |
Aliskiren
Riociguat Sildenafil (for pulmonary hypertension) Tadalafil (for pulmonary hypertension) | Not recommended during and 2 weeks after TOLSURA treatment. For sildenafil and tadalafil, see also Urologic Drugs below. |
Bosentan Guanfacine | Monitor for adverse reactions. Concomitant drug dose reduction may be necessary. |
| Contraceptives |
Dienogest Ulipristal | Monitor for adverse reactions. |
| Diuretics |
| Eplerenone | Contraindicated during and 2 weeks after TOLSURA treatment. |
| Gastrointestinal Drugs |
| Naloxegol | Contraindicated during and 2 weeks after TOLSURA treatment. |
Aprepitant Loperamide
| Monitor for adverse reactions. Concomitant drug dose reduction may be necessary. |
| Netupitant | Monitor for adverse reactions. |
| Immunosuppressants |
Everolimus Sirolimus Temsirolimus (IV) | Not recommended during and 2 weeks after TOLSURA treatment. |
Budesonide (inhalation)
Budesonide (noninhalation) Ciclesonide (inhalation) Cyclosporine (IV)
Cyclosporine (non-IV) Dexamethasone
| Fluticasone (inhalation)
Fluticasone (nasal) Methylprednisolone
Tacrolimus (IV)
Tacrolimus (oral) | Monitor for adverse reactions. Concomitant drug dose reduction may be necessary. |
| Lipid-Lowering Drugs |
Lomitapide Lovastatin
Simvastatin
| Contraindicated during and 2 weeks after TOLSURA treatment. |
| Atorvastatin
| Monitor for drug adverse reactions. Concomitant drug dose reduction may be necessary.
|
| Respiratory Drugs |
| Salmeterol | Not recommended during and 2 weeks after TOLSURA treatment. |
| SSRIs, Tricyclics and Related Antidepressants |
| Venlafaxine | Monitor for adverse reactions. Concomitant drug dose reduction may be necessary. |
Urologic Drugs |
| Avanafil | Contraindicated during and 2 weeks after TOLSURA treatment. |
| Fesoterodine | Patients with moderate to severe renal or hepatic impairment: Contraindicated during and 2 weeks after TOLSURA treatment. Other patients: Monitor for adverse reactions. Concomitant drug dose reduction may be necessary |
| Solifenacin | Patients with severe renal or moderate to severe hepatic impairment: Contraindicated during and 2 weeks after TOLSURA treatment. Other patients: Monitor for adverse reactions. Concomitant drug dose reduction may be necessary. |
Darifenacin Vardenafil | Not recommended during and 2 weeks after TOLSURA treatment. |
Dutasteride Oxybutynin
Sildenafil (for erectile dysfunction) Tadalafil (for erectile dysfunction and benign prostatic hyperplasia) Tolterodine | Monitor for adverse reactions. Concomitant drug dose reduction may be necessary. For sildenafil and tadalafil, see also Cardiovascular Drugs above. |
| | | |
| Miscellaneous Drugs and Other Substances |
| Colchicine | Patients with renal or hepatic impairment: Contraindicated during and 2 weeks after TOLSURA treatment.
Other patients: Not recommended during and 2 weeks after TOLSURA treatment. |
| Eliglustat | CYP2D6 EMstaking a strong or moderate CYP2D6 inhibitor, CYP2D6 IMs, or CYP2D6 PMs
: Contraindicated during and 2 weeks after TOLSURA treatment. CYP2D6 EMsnot taking a strong or moderate CYP2D6 inhibitor: Monitor for adverse reactions. Eliglustat dose reduction may be necessary. |
| Lumacaftor/Ivacaftor | Not recommended 2 weeks before, during, and 2 weeks after TOLSURA treatment. |
Alitretinoin (oral) Cabergoline Cannabinoids Cinacalcet Ivacaftor | Monitor for adverse reactions. Concomitant drug dose reduction may be necessary. |
| Vasopressin Receptor Antagonists |
Conivaptan Tolvaptan | Not recommended during and 2 weeks after TOLSURA treatment. |
| Drug Interactions with TOLSURA that Decrease Concomitant Drug Concentrations and May Reduce Efficacy of the Concomitant Drug |
| Antineoplastics |
| Regorafenib | Not recommended during and 2 weeks after TOLSURA treatment. |
| Gastrointestinal Drugs |
| Saccharomyces boulardii | Not recommended during and 2 weeks after TOLSURA treatment. |
| Nonsteroidal Anti-Inflammatory Drugs |
| Meloxicam
| Concomitant drug dose increase may be necessary. |